Search research articles
Contact Us
Filters
Showing results (41-50 of 139) with videos related to
Page
of 14
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
November 23, 2017
APOBEC3A Expression in Penile Squamous Cell Carcinoma
Martina Heller, Elena-Sophie Prigge, Adam Kaczorowski, et al.
Urologic Oncology
|
July 6, 2014
The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal-Implications for targeted therapies
Meike Schneider, Nina Korzeniewski, Konstanze Merkle, et al.
Cancers
|
December 23, 2022
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
Samaneh Eickelschulte, Anja Lisa Riediger, Arlou Kristina Angeles, et al.
Urologic Oncology
|
October 4, 2016
Molecular complexity of taxane-induced cytotoxicity in prostate cancer cells
Josef Mang, Konstanze Merkle, Martina Heller, et al.
Environmental and Molecular Mutagenesis
|
March 28, 2009
Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins
Anette Duensing, Nicole Spardy, Payel Chatterjee, et al.
Neoplasia (New York, N.Y.)
|
December 16, 2014
Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma
Xiaoguang Zhou, Yanis Tolstov, Aysenur Arslan, et al.
Cancer Research
|
August 27, 2009
Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin
Nicole Spardy, Kathryn Covella, Elliot Cha, et al.
EMBO Reports
|
March 24, 2012
Neurl4, a novel daughter centriole protein, prevents formation of ectopic microtubule organizing centres
Ji Li, Sehyun Kim, Tetsuo Kobayashi, et al.
Oncotarget
|
October 28, 2015
The ribosomal protein S6 in renal cell carcinoma: functional relevance and potential as biomarker
Maximilian Knoll, Stephan Macher-Goeppinger, Jürgen Kopitz, et al.
Frontiers in Oncology
|
December 25, 2024
Improved survival of patients with newly diagnosed oligometastatic prostate cancer through intensified multimodal treatment
Viktoria Schütz, Christopher-Leo Nessler, Anette Duensing, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 139) with videos related to
Sort By:
Page
of 14
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
November 23, 2017
APOBEC3A Expression in Penile Squamous Cell Carcinoma
Martina Heller, Elena-Sophie Prigge, Adam Kaczorowski, et al.
Urologic Oncology
|
July 6, 2014
The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal-Implications for targeted therapies
Meike Schneider, Nina Korzeniewski, Konstanze Merkle, et al.
Cancers
|
December 23, 2022
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
Samaneh Eickelschulte, Anja Lisa Riediger, Arlou Kristina Angeles, et al.
Urologic Oncology
|
October 4, 2016
Molecular complexity of taxane-induced cytotoxicity in prostate cancer cells
Josef Mang, Konstanze Merkle, Martina Heller, et al.
Environmental and Molecular Mutagenesis
|
March 28, 2009
Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins
Anette Duensing, Nicole Spardy, Payel Chatterjee, et al.
Neoplasia (New York, N.Y.)
|
December 16, 2014
Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma
Xiaoguang Zhou, Yanis Tolstov, Aysenur Arslan, et al.
Cancer Research
|
August 27, 2009
Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin
Nicole Spardy, Kathryn Covella, Elliot Cha, et al.
EMBO Reports
|
March 24, 2012
Neurl4, a novel daughter centriole protein, prevents formation of ectopic microtubule organizing centres
Ji Li, Sehyun Kim, Tetsuo Kobayashi, et al.
Oncotarget
|
October 28, 2015
The ribosomal protein S6 in renal cell carcinoma: functional relevance and potential as biomarker
Maximilian Knoll, Stephan Macher-Goeppinger, Jürgen Kopitz, et al.
Frontiers in Oncology
|
December 25, 2024
Improved survival of patients with newly diagnosed oligometastatic prostate cancer through intensified multimodal treatment
Viktoria Schütz, Christopher-Leo Nessler, Anette Duensing, et al.
Page
of 14